Alzamend director buys 108,388 more ALZN shares
Alzamend Neuro, Inc. (ALZN) director Milton C. Ault III reported additional purchases of common stock on April 14, 2026 in an amended Form 4.
Rhea-AI Filing Summary
Alzamend Neuro, Inc. (ALZN) director Milton C. Ault III reported additional purchases of common stock on April 14, 2026 in an amended Form 4. An affiliated entity, Ault Lending, LLC, bought 108,388 shares at $1.0047 per share, and Ault personally bought 2,000 shares with a volume weighted average price of $1.0338, in open market transactions. Following these transactions, reported holdings include 116,648 indirect shares via Ault Lending, 11,068 indirect shares via Ault Life Sciences, Inc., 61 indirect shares via Ault Life Sciences Fund, LLC, and 2,000 direct shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 110,388 shares
Net Buy
4 txns
Insider
AULT MILTON C III
Role
Director
Bought
110,388 shs ($111K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock F1 | 108,388 | $1.0047 | $109K |
| Purchase | Common Stock F2 | 2,000 | $1.0338 | $2K |
| holding | Common Stock F3 | -- | -- | -- |
| holding | Common Stock F4 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 116,648 shares (Indirect, By Ault Lending, LLC);
Common Stock — 2,000 shares (Direct);
Common Stock — 11,068 shares (Indirect, By Ault Life Sciences, Inc.);
Common Stock — 61 shares (Indirect, By Ault Life Sciences Fund, LLC)
Footnotes (4)
- F1. Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Hyperscale Data, Inc. ("HSD"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
- F2. The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $1.0338. The range of purchase prices on the transaction date was $1.00 to $1.05 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
- F3. Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
- F4. Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.
Key Figures
Shares purchased via Ault Lending, LLC: 108,388 shares
Price per share via Ault Lending, LLC: $1.0047 per share
Direct shares purchased by reporting person: 2,000 shares
+5 more
8 metrics
Shares purchased via Ault Lending, LLC
108,388 shares
Common stock purchased on April 14, 2026, indirect ownership
Price per share via Ault Lending, LLC
$1.0047 per share
Common stock purchase on April 14, 2026
Direct shares purchased by reporting person
2,000 shares
Common stock purchased on April 14, 2026, direct ownership
Volume weighted average purchase price
$1.0338 per share
Direct open market purchases on April 14, 2026; trade range $1.00–$1.05
Indirect holdings via Ault Lending, LLC
116,648 shares
Total shares following transaction as of April 14, 2026
Indirect holdings via Ault Life Sciences, Inc.
11,068 shares
Reported holding entry dated April 14, 2026
Indirect holdings via Ault Life Sciences Fund, LLC
61 shares
Reported holding entry dated April 14, 2026
Direct holdings after transactions
2,000 shares
Total direct shares following April 14, 2026 purchases
Key Terms
Form 4/A, open market transactions, volume weighted average purchase price, indirect, +1 more
5 terms
Form 4/A regulatory
"The original Form 4 filed on April 16, 2026 is amended by this Form 4/A"
Form 4/A is an amended filing that corrects or updates an earlier Form 4, the mandatory report that insiders (like company executives, directors, or large shareholders) must file when their ownership stakes change. Think of it as an edited receipt showing who bought or sold stock and when; investors use it to track insider confidence, detect potential conflicts, and spot trading patterns that might signal future company prospects.
open market transactions financial
"The common stock was purchased by the reporting person in open market transactions"
Open market transactions are the buying and selling of a company’s shares or other securities conducted on public exchanges or through the wider market rather than through private deals or negotiated placements. They matter to investors because these trades change supply and demand in real time—like shoppers affecting a store’s inventory—and so can move prices, signal management or investor sentiment, affect liquidity, and alter ownership stakes that influence future returns and risk.
volume weighted average purchase price financial
"with a volume weighted average purchase price of $1.0338"
The volume weighted average purchase price is the average price an investor paid for a security, calculated by giving more weight to prices where more shares were bought—so large trades move the average more than small ones. Investors use it like a cost-basis yardstick to see whether current market prices are above or below what they effectively paid, helping judge gains, losses, and whether to sell or add to a position.
indirect financial
"total_shares_following_transaction 116648.0000, direct_or_indirect I"
voting and investment power financial
"is deemed to have voting and investment power with respect to the securities"
FAQ
What insider transactions were reported for ALZN in this amended Form 4?
The filing reports two purchases of Alzamend Neuro common stock on April 14, 2026: 108,388 shares bought indirectly via Ault Lending, LLC at $1.0047 per share and 2,000 shares bought directly by Milton C. Ault III with a volume weighted average price of $1.0338.
Why was this ALZN Form 4/A filed as an amendment?
The amendment was filed to add shares that were inadvertently omitted from the original April 16, 2026 Form 4. The filer states that, other than this correction, no changes were made to the previously reported transactions or holdings.
AI-generated analysis. How Rhea-AI works. Not financial advice.
